88 followers
RT @JournalofGISurg: NSQIP risk prediction remains relevant for rarer diseases. A November issue paper https://t.co/4rYNgIPOiG closely exa…
9,156 followers
RT @JournalofGISurg: NSQIP risk prediction remains relevant for rarer diseases. A November issue paper https://t.co/4rYNgIPOiG closely exa…
1,618 followers
RT @OSUSurgery: Hot off the press from our own @mary_dillhoff with primary authorship by one of our stellar residents, Apeksha Dave. Contin…
4,533 followers
Hot off the press from our own @mary_dillhoff with primary authorship by one of our stellar residents, Apeksha Dave. Continuing to encourage careful consideration when utilizing risk calculators to tailor treatment decisions for our patients!
6,483 followers
NSQIP risk prediction remains relevant for rarer diseases. A November issue paper https://t.co/4rYNgIPOiG closely examining the use of the ACS NSQIP Risk Calc and pancreas neuroendocrine tumor resections from ApekshaDave @mary_dillhoff @OSUSurgery (VisAb
9,156 followers
RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine…
405 followers
#RT @JournalofGISurg: RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group https://t.co/nPpTVBwwxg #NSQIP @JournalofGISurg
6,937 followers
RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine…
6,483 followers
RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine…
23,490 followers
RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine…
729 followers
RT @AmCollSurgeons: Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine…
85,516 followers
Evaluating the ACS NSQIP Risk Calculator in Primary Pancreatic Neuroendocrine Tumor: Results from the US Neuroendocrine Tumor Study Group https://t.co/Abqq8N4Ylj #NSQIP @JournalofGISurg